Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia

ClinicalTrials.gov ID: NCT00302016

Public ClinicalTrials.gov record NCT00302016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multicenter, Expanded Access Study of Oral AMN107 in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase, or Chronic Phase.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will further evaluate if AMN107 is safe in adults with chronic myeloid leukemia who are resistant or intolerant to imatinib and to provide patients access to this new drug until the drug becomes commercially available.

Study identification

NCT ID
NCT00302016
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2006 (Type not available)
Primary completion
Nov 2008 (Actual)
Completion
Not listed
Last update posted
Aug 26, 2011

Started 2006

United States locations

U.S. sites
59
U.S. states
30
U.S. cities
51
Facility City State ZIP Site status
University of South Alabama Cancer Research Institute Mobile Alabama 36693 —
Arizona Cancer Center Tucson Arizona 85724 —
City of Hope National Medical Center Duarte California 91010 —
Antelope Valley Cancer Center Lancaster California 93534 —
Stanford University Palo Alto California 94304 —
University of Colorado Aurora Colorado 80010 —
Rocky Mountain Cancer Center Denver Colorado 80218 —
Georgetown University Medical Center-Lombardi Cancer Center Washington D.C. District of Columbia 20007-2113 —
Washington Cancer Institute Washington D.C. District of Columbia 20010 —
Osler Medical Inc./Osler Clinical Research Melbourne Florida 32901 —
Advanced Medical Specialties Miami Florida 33176 —
Integrated Community Orange Park Florida 32073 —
Florida Hospital Cancer Institute Orlando Florida 32804 —
MD Anderson Cancer Center Orlando Florida 32806 —
Hematology Oncology Assoc. Pensacola Florida 32501 —
Emory University Cancer Institute Atlanta Georgia 30322 —
Medical College of Georgia Augusta Georgia 30912 —
Rush University Medical Center Chicago Illinois 60612 —
Stroger Cook County Hospital Chicago Illinois 60612 —
University of Illinois at Chicago Chicago Illinois 60612 —
University of Chicago Hospital Chicago Illinois 60637 —
Loyola University Medical Center Maywood Illinois 60153 —
St. Francis Hospital & Health Centers Beech Grove Indiana 46107 —
University of Iowa Hospitals & Clinics Iowa City Iowa 52242 —
Cancer Center of Kansas Wichita Kansas 67214 —
Louisville Oncology Research Louisville Kentucky 40202 —
LSU Health Sciences Center Shreveport Louisiana 71103 —
St. Agnes Hospital Baltimore Maryland 21229 —
University of Michigan Ann Arbor Michigan 48109 —
Wayne State University Detroit Michigan 48201 —
St. John Hospital and Medical Center Grosse Pointe Michigan 48236 —
Mayo Clinic Hospital Rochester Minnesota 55905 —
Southeast Nebraska Cancer Center Lincoln Nebraska 68516 —
Nebraska Methodist Cancer Center Omaha Nebraska 68114 —
Nevada Cancer Institute Las Vegas Nevada 89135 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
University of New Mexico Health Sciences Center Albuquerque New Mexico 87131 —
Cancer Institute of New Mexico Santa Fe New Mexico 87505 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Winthrop Hematology/Oncology Mineola New York 11501 —
Memorial Sloan Kettering Cancer Center New York New York 10017 —
Weill Cornell Medical Center New York New York 10021 —
Mount Sinai Medical Center New York New York 10029 —
University of Rochester Medical Center Rochester New York 14642 —
Duke University Durham North Carolina 27710 —
Wake Forest University Winston-Salem North Carolina 27157 —
Cancer Care Associates Oklahoma City Oklahoma 734112 —
Cancer Care Associates Tulsa Oklahoma 74136 —
Oregon Health Sciences University Portland Oregon 97239 —
Western Pennsylvania Cancer Institute Pittsburgh Pennsylvania 15224 —
Charleston Hematology Oncology Charleston South Carolina 29403 —
MUSC Hollings Cancer Center Charleston South Carolina 29425 —
Three Medical Park Columbia South Carolina 29203 —
Cancer Center of the Carolinas Greenville South Carolina 29615 —
The Jones Clinic Germantown Tennessee 38138 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
UT Southwestern Medical Center Dallas Texas 75390 —
Utah Cancer Specialists Salt Lake City Utah 84106 —
Swedish Cancer Institute Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 211 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00302016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2011 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00302016 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →